Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.
CAR T-cell therapies are a revolutionary form of treatment for patients with cancer, but it does come with its unique adverse events.
Inna Tsuker, PharmD, BCPS, Cancer Treatment Centers of America, discusses the Qutenza patch, a little-known treatment for neuropathic pain.
David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses caring for patients with glioblastoma.
Robin McConnell, from John Theurer Cancer Center, Discusses Nutrition in Cancer Care
This article reviews the types of genes included in multigene panels for breast cancer, and the risks associated with those genes.
Jean Weigert, MD, head of breast imaging for the Hospital of Central Connecticut, discusses a study conducted in Connecticut to see if the addition of screening breast ultrasound in women with mammographically normal but dense breasts has increased breast cancer detection.
My story serves as a reminder that every patient and family I meet as an oncology nurse navigator deserves the care I wanted my father to have.
Rapid changes occurring nationally and worldwide—including shifts in demographics, languages, epidemiological patterns, and social systems— have direct implications for patient care. These trends are projected to continue, and nurses need to be prepared to care for increasingly diverse patient populations.
For most families across the country, September is notable as the first full month back at school. September marks the end of carefree summer days and a return to routine: Packing lunches. Rushing out the door. Homework before dinner. Bedtime battles.
"Male nurses are found to earn about $5,000 more than female colleagues." (Not quite) shocking news!
While treatment options for lung cancer have vastly improved over the last decade, attitudes toward the disease have actually gotten worse.
As life expectancies grow longer in Lebanon, there is an increase in the amount of people diagnosed with cancer.
Wendy Sanchez, ARNP, Florida Cancer Specialists, discusses treating patients with breakthrough cancer pain.
With minimally invasive procedures to test lung cancer tumors, there often isn't enough tissue to undergo a full biomarker test, pointing toward the strength of liquid biopsies, explained Lynette M. Sholl, MD, chief of thoracic pathology at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and associate professor at Harvard Medical School.
There are concerns when a patient undergoes a cytoreductive nephrectomy after immunotherapy or targeted therapy that nurses should be aware of.
Olga Ivanov, MD, surgeon at the Florida Hospital Cancer Institute, discusses survivorship in breast cancer.
Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.
Guided imagery intervention helped evaluate perceived stress levels among registered nurses, nurse educators and patient care associates.
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
With the inception of its Precision Cancer Therapies Program, the Ochsner Cancer Institute has been able to expand availability of early phase clinical trials to patients who might otherwise have had to drive up to 5 or 6 hours to participate in one.
In light of the COVID-19 pandemic, transplant-eligible patients with cancer are undergoing careful assessment to determine whether they should proceed with the procedure or receive additional consolidation therapy to buy time, according to Naval G. Daver, MD.
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.
Dr. Puneeth Iyengar expresses the importance of nutrition and hydration for patients with stage III lung cancer.
One of the great mysteries in oncology practice is the return of breast cancer many years after its initial diagnosis and treatment. And by many years, I mean 15 or even 20 years later, at a time when a woman least expects it to return.
Recent research highlighted the need for reliable information to address the educational and psychosocial needs of patients with newly diagnosed metastatic breast cancer.
Nina Kaden-Lottick describes some common challenges in survivor care.
Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow.